Together, they help maintain overall endocrine health
Two groups received consistent weekly doses of 0.3 mg and 0.6 mg throughout the 26-week study, while three groups saw their dosages escalated every two weeks to reach 1.2, 2.4, and 4.5 mg/week
Efficacy and safety of iGlarLixi, fixed-ratio combination of insulin glargine and lixisenatide, compared with basal-bolus regimen in patients with type 2 diabetes: propensity score matched analysis
In a multicentre, examiner-blind, clinical and neurophysiological study lasting 4 months, 120 hands from 82 patients with mild-to-moderate carpal tunnel syndrome were examined at baseline and 10, 60, and 120 days after treatment with 500 mg of acetyl-l-carnitine twice daily for 10 days intramuscularly followed by oral administration at 500 mg twice daily for 4 months